Search

Mar 07, 2025
Foundation Accepting Letters of Intent for 2025 Grants
The Doctors Company Foundation is currently accepting Letters of Intent for its 2025 grant cycle. Letters of Intent will be accepted through the end of business on Wednesday, March 19, 2025.
From The Doctor’s Advocate

The Doctors Company Announces $14.7 Million Dividend
The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, announced today that it has approved a 2024 premium dividend of approximately $14.7 million, bringing the total of declared dividends to date to $470 million.

The Industry’s Strongest Malpractice Claims Defense
The Doctors Company is founded and led by physicians, which gives us a keen understanding of the impact of a malpractice claim. If a claim is ever made against you, we fight to win—both in and out of the courtroom.

January 30, 2024, MDLinx
A Georgia Man's Failed Heart Transplant Culminates In a $38.6M Malpractice Verdict Against Emory Healthcare
Robert White, President of The Doctors Company and TDC Group, discusses some of the causes of the rise in high-dollar medical malpractice verdicts.

February 08, 2024, Becker's ASC Review
Malpractice Mega-Verdicts Hit Record High
Robert White, President of The Doctors Company and TDC Group, discusses how a rollback of tort reform could be a factor in the rise of nuclear malpractice verdicts.

2025 AM Best Rate Revision
AM Best has revised the outlooks to positive from stable and affirmed The Doctors Company's financial strength rating (FSR) of A (Excellent) and the long-term issuer credit rating (ICR) of "a+”. The positive outlooks, FSR of A, and long-term ICR of “a+” have been affirmed for The Doctors Company, an Interinsurance Exchange, and its core subsidiaries, which collectively comprise The Doctors Company Insurance Group (TDC or TDC Group). 

The Doctors Company Announces $8.5 Million Member Dividend
We are proud to announce The Doctors Company has approved a 2023 premium dividend of approximately $8.5 million, bringing the total of declared dividends to date to more than $455 million.

Cost and Impact of Defensive Medicine
Physicians practice defensive medicine all the time—some acknowledge and accept it, while others believe it is untrue and unconscionable. The Doctors Company CEO and Chairman Richard E. Anderson, MD, FACP, examines the pervasive nature of defensive medicine in this article.

Mar 04, 2024
Loss Lessons: Practicing Out of Bounds
Our complimentary on-demand course provides strategies for establishing policies and protocols to address scope of practice for unlicensed staff.
From The Doctor’s Advocate

Obstetrics: Reduce Risk of Shoulder Dystocia
Shoulder dystocia is a rare complication of vaginal delivery. The purpose of this study was to better understand factors that may contribute to medical malpractice claims with SD and to offer recommendations to practicing obstetricians regarding the management of SD.